Johnson & Johnson Vision, a global enterprise in eye health and part of the Johnson & Johnson medical devices companies, recently announced the availability of Tecnis Synergy Toric II OptiBlue PC-IOL for patients with astigmatism in India. Technis Synergy Toric II IOL, is a continuous-range-of-vision lens engineered for rotational stability, which locks in visual performance and provides high-quality vision1 .
Cataracts are the leading cause of preventable blindness worldwide, impacting more than 100 million eyes, with more than 90% of people developing cataracts by the age of 65.2,3 Most people will develop cataracts at some point in their life, and modern cataract surgery is a safe and effective treatment that has a success rate of nearly 98%.4 In India, nearly 73% of adults 60 years and older have cataracts5 and if left untreated, cause vision to deteriorate over time. Astigmatism reduces distance and near visual acuity, vision quality, and depth perception.6,7 All cataracts will eventually need to be surgically removed and replaced with an artificial lens, called an IOL (intraocular lens).
Burzin Shahana, country manager at Johnson & Johnson Vision, Surgical Vision India, said, “At Johnson & Johnson Vision, we are deeply engaged with Indian health care professionals to reduce cataract burden through innovative, quality-based technologies and products. Tecnis Synergy Toric II OptiBlue PC-IOL is an advanced IOL solution for cataract patients with astigmatism and gives patients the visual clarity and increased spectacle independence to improve their current lifestyles.” He also added, “The launch will also expand available options physicians have to provide value to their patients with astigmatism.”
Tecnis Synergy Toric II OptiBlue PC-IOL (intraocular lens) offers an opportunity to address both presbyopia and astigmatism at the time of cataract surgery.8 It’s designed to:
- Provide continuous vision over a full range of distances, including far, intermediate and near, to increase spectacle independence. These Toric IOLs compensate for corneal spherical aberration and corneal astigmatism. 1
- The posterior optic of the lens has a proprietary diffractive surface designed to correct chromatic aberration for enhanced contrast sensitivity and provide high-quality vision over a full range of distances. The diffractive design of this lens leads to high visual acuities across all distances and a continuous range of vision from far through near, resulting in increased spectacle independence. 1
- New frosted haptic design increases the amount of friction between the lens haptic surface and the capsular bag to lock in the intraocular lens for rotational stability and visual performance.
In India, Tecnis Synergy Toric II OptiBlue PC-IOL has been approved by the Central Drugs Standard Control Organisation (CDSCO).
*Johnson & Johnson Vision represents the products and services of Johnson & Johnson Surgical Vision, Inc., Johnson & Johnson Vision Care, Inc., and the affiliates of both.
**The Johnson & Johnson Medical Devices Companies comprise the surgery, orthopedics, vision, and interventional solutions businesses within Johnson & Johnson’s Medical Devices segment.
1 Tecnis Synergy Toric II OptiBlue IOL Pack Insert
2 World Health Organization. Blindness and Impairment. https://www.who.int/en/news-room/fact-sheets/detail/blindness-and-visual-impairment
3 Kellogg Eye Center. Cataract. www.umkelloggeye.org/conditions-treatments/cataract
4 Vision Health Initiative, Common Eye Disorders. Centers for Disease Control and Prevention. https://www.cdc.gov/visionhealth/basics/ced/index.html
5 Vashist P, Talwar B, Gogoi M, Maraini G, Camparini M, Ravindran RD, Murthy GV, Fitzpatrick KE, John N, Chakravarthy U, Ravilla TD, Fletcher AE. Prevalence of cataract in an older population in India: the India study of age-related eye disease. Ophthalmology. 2011 Feb;118(2):272-8.e1-2.
6 Wolffsohn JS, Bhogal G, Shah S (2011) Effect of uncorrected astigmatism on vision. J Cataract Refract Surg 37 (3): 454-460. 7 Read SA, Vincent SJ, Collins MJ (2014) The visual and functional impacts of astigmatism and its clinical management. Ophthalmic Physiol Opt 34 (3): 267-294.
7 8 https://www.beyondcataracts.com/cataract-treatment/tecnis-synergy-iols – accessed on 4th Nov’22 PP2022CT5406
